DPEP3 inhibitors belong to a distinct chemical class that specifically targets and modulates the activity of dipeptidase 3 (DPEP3). DPEP3 is an enzyme involved in various metabolic processes, particularly the hydrolysis of dipeptides and other small peptides. The inhibitors of this class are designed to interact with the active site of DPEP3, thereby inhibiting its enzymatic function. By binding to DPEP3, these inhibitors block the enzyme from catalyzing the breakdown of dipeptides, leading to the accumulation of these molecules within the biological system. The chemical structure of DPEP3 inhibitors is characterized by specific functional groups and molecular motifs that facilitate their interaction with the enzyme. Through this interaction, DPEP3 inhibitors display a high binding affinity and selectivity towards DPEP3, ensuring effective inhibition of its enzymatic activity.
In laboratory settings, researchers utilize DPEP3 inhibitors as valuable tools to investigate the role of DPEP3 in cellular and biochemical processes. By blocking the enzymatic activity of DPEP3, these inhibitors help elucidate the downstream effects and functions that depend on DPEP3-mediated peptide hydrolysis. This enables scientists to gain a deeper understanding of the complex interplay between DPEP3 and its associated pathways, uncovering novel insights into physiological and pathological processes. Overall, DPEP3 inhibitors represent a chemical class that specifically targets and inhibits the activity of DPEP3, a key enzyme involved in peptide metabolism. While their applications are beyond the scope of this description, the inhibitors serve as valuable research tools in laboratory settings, facilitating the exploration of DPEP3's biological functions and its implications in various physiological processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bestatin | 58970-76-6 | sc-202975 | 10 mg | $131.00 | 19 | |
Bestatin is a naturally occurring compound that inhibits various aminopeptidases, including DPEPIt has been studied for its potential anti-tumor and immunomodulatory effects. | ||||||
Linagliptin | 668270-12-0 | sc-364721 sc-364721A | 5 mg 10 mg | $260.00 $426.00 | 2 | |
Linagliptin is a DPP-IV inhibitor that indirectly affects DPEP3 activity. It is an approved drug for type 2 diabetes and works by increasing the levels of incretin hormones, which regulate glucose metabolism. | ||||||
Saxagliptin | 361442-04-8 | sc-473161 | 1 mg | $360.00 | ||
Saxagliptin is a DPP-IV inhibitor that indirectly influences DPEPIt is investigated for type 2 diabetes and works by increasing the levels of active incretin hormones. | ||||||
Teneligliptin | 760937-92-6 (free base) | sc-475074 | 25 mg | $260.00 | 1 | |
Teneligliptin is a DPP-IV inhibitor that indirectly influences DPEP3 activity. It is used for the management of type 2 diabetes and has been approved in certain countries, including Japan and India. | ||||||
Gemigliptin tartrate | 1374639-74-3 | sc-507281 | 10 mg | $165.00 | ||
Gemigliptin is a selective DPP-IV inhibitor that indirectly affects DPEP3. It is investigated for type 2 diabetes in South Korea and has shown efficacy in improving glycemic control. | ||||||